Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Gets Access To Physicians’ Online Conversations Through Sermo Deal

Executive Summary

Pfizer will have the opportunity to offer physicians clinical information related to their online discussions under a deal with the social networking site Sermo

You may also be interested in...



Social Networking Sites: Small Step For Firms, Giant Leap For Research

As social networking Web sites court big pharma with new services, firms now must decide whether such forums can play a useful role in collecting data and monitoring markets

Social Networking Sites: Small Step For Firms, Giant Leap For Research

As social networking Web sites court big pharma with new services, firms now must decide whether such forums can play a useful role in collecting data and monitoring markets

FDA/WebMD Partnership Is Data-Gathering Opportunity

Deal with WebMD enables FDA to reach more consumers though online polling techniques; the agency will also provide videos to the consumer Web site.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel